RT Book, Section A1 Salenger, Page V. A2 Knicely, Daphne H. A2 Abdel-Rahman, Emaad M. A2 Greenberg, Keiko I. SR Print(0) ID 1178969870 T1 Mineral Bone Disease in Home Hemodialysis T2 Handbook of Home Hemodialysis YR 2021 FD 2021 PB McGraw Hill PP New York, NY SN 9781260458633 LK accessmedicine.mhmedical.com/content.aspx?aid=1178969870 RD 2024/10/07 AB Mineral bone disease (MBD) is best described as a syndrome that encompasses altered bone morphology and vascular calcification, as well as abnormalities in serum markers of bone activity. The older term of “renal osteodystrophy” specifically refers to pathological variants noted on bone biopsy in patients with chronic kidney disease (CKD); however, bone biopsies are rarely performed in a clinical setting and are used now primarily for research purposes. Typically, the incidence of MBD rises as CKD progresses to end-stage kidney disease (ESKD); however, the disease may not be clinically apparent until the patient is approaching imminent need for dialysis.